Cargando…

Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer

BACKGROUND: Colorectal cancer (CRC) is 3rd most commonly diagnosed cancer in males and the second in females. PD-1/PD-L1 axis, as an immune checkpoint, is up-regulated in many tumors and their microenvironment. However, the prognostic value of PD-1/PD-L1 in CRC remains unclear. METHODS: The Cancer G...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yaqi, Liang, Lei, Dai, Weixing, Cai, Guoxiang, Xu, Ye, Li, Xinxiang, Li, Qingguo, Cai, Sanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995750/
https://www.ncbi.nlm.nih.gov/pubmed/27552968
http://dx.doi.org/10.1186/s12943-016-0539-x
_version_ 1782449534896439296
author Li, Yaqi
Liang, Lei
Dai, Weixing
Cai, Guoxiang
Xu, Ye
Li, Xinxiang
Li, Qingguo
Cai, Sanjun
author_facet Li, Yaqi
Liang, Lei
Dai, Weixing
Cai, Guoxiang
Xu, Ye
Li, Xinxiang
Li, Qingguo
Cai, Sanjun
author_sort Li, Yaqi
collection PubMed
description BACKGROUND: Colorectal cancer (CRC) is 3rd most commonly diagnosed cancer in males and the second in females. PD-1/PD-L1 axis, as an immune checkpoint, is up-regulated in many tumors and their microenvironment. However, the prognostic value of PD-1/PD-L1 in CRC remains unclear. METHODS: The Cancer Genome Atlas (TCGA) database (N = 356) and Fudan University Shanghai Cancer Center (FUSCC) cohort of patients (N = 276) were adopted to analyze the prognostic value of PD-L1 in colorectal tumor cells (TCs) and of PD-1 in tumor infiltrating cells (TILs) for CRC. Subgroup analyses were conducted in FUSCC cohort according to patients’ status of mismatch repair. RESULTS: In TCGA cohort, the cut-off values of PD-1 and PD-L1 expression were determined by X-tile program, which were 4.40 and 2.92, respectively. Kaplan-Meier analysis indicated that higher PD-1 and PD-L1 expressions correlated with better OS (P = 0.032 and P = 0.002, respectively). In FUSCC cohort, expressions of PD-1 on TILs and PD-L1 on TCs were analyzed separately by immunohistochemistry (IHC) staining based on a TMA sample (N = 276) and revealed that both TILs-PD-1 and TCs-PD-L1 were associated with OS (P = 0.006 and P = 0.002, respectively) and DFS (P = 0.025 and P = 0.004, respectively) of CRC patients. Multivariate Cox regression analysis indicated TILs-PD-1 was an independent prognostic factor both for OS and DFS of CRC patients (P < 0.05). Subgroup analyses showed that TILs-PD-1 was an independent prognostic factor for both OS and DFS in CRC patients in MSS-proficient subgroup (P < 0.05), while neither of them correlated with OS or DFS in MSS-deficient subgroup (P > 0.05). CONCLUSIONS: Higher expressions of PD-1 and PD-L1 correlates with better prognosis of CRC patients. TILs-PD-1 is an independent prognostic factor for OS and DFS of CRC patients, especially for MMR-proficient subgroup. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-016-0539-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4995750
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49957502016-08-25 Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer Li, Yaqi Liang, Lei Dai, Weixing Cai, Guoxiang Xu, Ye Li, Xinxiang Li, Qingguo Cai, Sanjun Mol Cancer Research BACKGROUND: Colorectal cancer (CRC) is 3rd most commonly diagnosed cancer in males and the second in females. PD-1/PD-L1 axis, as an immune checkpoint, is up-regulated in many tumors and their microenvironment. However, the prognostic value of PD-1/PD-L1 in CRC remains unclear. METHODS: The Cancer Genome Atlas (TCGA) database (N = 356) and Fudan University Shanghai Cancer Center (FUSCC) cohort of patients (N = 276) were adopted to analyze the prognostic value of PD-L1 in colorectal tumor cells (TCs) and of PD-1 in tumor infiltrating cells (TILs) for CRC. Subgroup analyses were conducted in FUSCC cohort according to patients’ status of mismatch repair. RESULTS: In TCGA cohort, the cut-off values of PD-1 and PD-L1 expression were determined by X-tile program, which were 4.40 and 2.92, respectively. Kaplan-Meier analysis indicated that higher PD-1 and PD-L1 expressions correlated with better OS (P = 0.032 and P = 0.002, respectively). In FUSCC cohort, expressions of PD-1 on TILs and PD-L1 on TCs were analyzed separately by immunohistochemistry (IHC) staining based on a TMA sample (N = 276) and revealed that both TILs-PD-1 and TCs-PD-L1 were associated with OS (P = 0.006 and P = 0.002, respectively) and DFS (P = 0.025 and P = 0.004, respectively) of CRC patients. Multivariate Cox regression analysis indicated TILs-PD-1 was an independent prognostic factor both for OS and DFS of CRC patients (P < 0.05). Subgroup analyses showed that TILs-PD-1 was an independent prognostic factor for both OS and DFS in CRC patients in MSS-proficient subgroup (P < 0.05), while neither of them correlated with OS or DFS in MSS-deficient subgroup (P > 0.05). CONCLUSIONS: Higher expressions of PD-1 and PD-L1 correlates with better prognosis of CRC patients. TILs-PD-1 is an independent prognostic factor for OS and DFS of CRC patients, especially for MMR-proficient subgroup. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-016-0539-x) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-24 /pmc/articles/PMC4995750/ /pubmed/27552968 http://dx.doi.org/10.1186/s12943-016-0539-x Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Li, Yaqi
Liang, Lei
Dai, Weixing
Cai, Guoxiang
Xu, Ye
Li, Xinxiang
Li, Qingguo
Cai, Sanjun
Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
title Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
title_full Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
title_fullStr Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
title_full_unstemmed Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
title_short Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
title_sort prognostic impact of programed cell death-1 (pd-1) and pd-ligand 1 (pd-l1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995750/
https://www.ncbi.nlm.nih.gov/pubmed/27552968
http://dx.doi.org/10.1186/s12943-016-0539-x
work_keys_str_mv AT liyaqi prognosticimpactofprogramedcelldeath1pd1andpdligand1pdl1expressionincancercellsandtumorinfiltratinglymphocytesincolorectalcancer
AT lianglei prognosticimpactofprogramedcelldeath1pd1andpdligand1pdl1expressionincancercellsandtumorinfiltratinglymphocytesincolorectalcancer
AT daiweixing prognosticimpactofprogramedcelldeath1pd1andpdligand1pdl1expressionincancercellsandtumorinfiltratinglymphocytesincolorectalcancer
AT caiguoxiang prognosticimpactofprogramedcelldeath1pd1andpdligand1pdl1expressionincancercellsandtumorinfiltratinglymphocytesincolorectalcancer
AT xuye prognosticimpactofprogramedcelldeath1pd1andpdligand1pdl1expressionincancercellsandtumorinfiltratinglymphocytesincolorectalcancer
AT lixinxiang prognosticimpactofprogramedcelldeath1pd1andpdligand1pdl1expressionincancercellsandtumorinfiltratinglymphocytesincolorectalcancer
AT liqingguo prognosticimpactofprogramedcelldeath1pd1andpdligand1pdl1expressionincancercellsandtumorinfiltratinglymphocytesincolorectalcancer
AT caisanjun prognosticimpactofprogramedcelldeath1pd1andpdligand1pdl1expressionincancercellsandtumorinfiltratinglymphocytesincolorectalcancer